CJC-1295 no DAC – 5mg

£40.99

High-purity CJC-1295 No DAC research peptide, independently third-party tested. Stocked, quality-controlled and dispatched directly from the UK. A synthetic 29-amino-acid GHRH analogue supplied as a lyophilised powder for laboratory research use only.

  • Clinical grade
  • High purity guarantee
  • Free UK Shipping - Orders over £100

678 in stock

Purchase & earn 41 points!

About CJC-1295

CJC-1295 is a synthetic growth hormone-releasing hormone analogue developed to extend the activity of GHRH-related signalling. Research describes CJC-1295 as a long-acting GHRH analogue studied for its pharmacokinetic and pharmacodynamic effects on growth hormone and IGF-1 secretion. It has also been described as a 30-amino-acid peptide-based compound in detection and screening research, making it suitable to describe as a GHRF-family research peptide.

  • 5mg vial
  • Lyophilised powder format
  • Clear product and storage information
  • Third-party tested where applicable
  • Research use only-

Reviews

There are no reviews yet

Be the first to review “CJC-1295 no DAC – 5mg”

Your email address will not be published. Required fields are marked *

Why Choose Healand Research

Clinician Grade

Developed with scientific and clinical insight to deliver research products you can trust.

High Quality

Manufactured using carefully selected, high-quality raw materials and rigorous production standards.

Third-Party Tested

Every batch undergoes independent third-party testing to verify purity, identity, and consistency before release.

Frequently bought with your items

CJC-1295 is a research peptide from the growth-hormone releasing factor family.

No. It is supplied strictly for research purposes only.

Keep refrigerated between 2°C and 8°C and away from direct light.

Selected Healand Labs peptides are tested for quality, purity and consistency.

Reviews

I was a bit unsure where to start with peptides, but the Healand Labs range made everything feel much clearer. The product pages are easy to understand, and I liked seeing the focus on purity, third-party testing and UK stock. It feels professional without being confusing.

Steve, R